By Dan Catchpole and Aatreyee Dasgupta (Reuters) - Canadian business jet manufacturer Bombardier (OTC:BDRBF) reported higher first-quarter revenue on Thursday, owing to increased aircraft deliveries and growth in aftermarket services, but the company’s gains fell slightly short of investor expectations. Bombardier President and CEO Eric Martel said he sees more opportunities than dangers amid th ...
By Kalea Hall DETROIT (Reuters) - General Motors (NYSE:GM) cut its 2025 profit forecast on Thursday after receiving some clarity and a reprieve from the White House this week on automotive tariffs. CEO Mary Barra told shareholders in a letter that the company would maintain dialogue with the Trump administration on trade and other policies as they evolve. "There are ongoing discussions ...
By Kenneth Li NEW YORK (Reuters) -Thomson Reuters on Thursday confirmed 2025 financial guidance amid tariff-induced global economic turmoil that has led some companies to revise or scrap forecasts altogether. The Toronto-based content and technology company reported quarterly revenue rising 1% to $1.9 billion, slightly below analyst expectations of $1.93 billion, according to LSEG data. Organic re ...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health (NYSE:CVS)’s decision to drop the company’s obesity drug Zepbound from the list of medicines it covers for reimbursement dragged shares down nearly 7%. CVS said its pharmacy benefit management unit, which is the largest in the U.S., would drop Zepbound coverage f ...